Drug · DIN 02238192
BROMOCRIPTINE
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since September 3, 1998; first marketed September 3, 1998.
- Drug Identification Number (DIN)
- 02238192
- Company (DIN owner)
- Pharmel Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Bromocriptine G02CB01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BROMOCRIPTINE (BROMOCRIPTINE MESYLATE) | 2.5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 19, 1998: NOC 2723New Drug Submission (NDS)
Other DINs named BROMOCRIPTINE
- DIN 02087324 · Marketed
- DIN 02230454 · Marketed
- DIN 02238193 · Cancelled Post Market